"Designing Growth Strategies is in our DNA"

Infusion Pump Market Size, Share & COVID-19 Impact Analysis, By Type (Volumetric Pumps, Syringe Pumps, Enteral Pumps, Insulin Pumps, Elastomeric Pumps, Implantable Pumps, and PCA Pumps), By Application (Diabetes, Oncology, Pain Management, and Others), By End User (Hospitals & Clinics, Ambulatory Care Settings, Home Care Settings, and Others), and Regional Forecast, 2021-2028

Region : Global | Format: PDF | Report ID: FBI102554

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

The global infusion pump market size was USD 9.02 billion in 2020. The market is projected to grow from USD 9.67 billion in 2021 to USD 15.81 billion in 2028 at a CAGR of 7.3% in the 2021-2028 period. The global impact of COVID-19 has been unprecedented and staggering, with market witnessing a negative impact on demand across all regions amid the pandemic. Based on our analysis, the global market will exhibit a lower growth of 6.80% in 2020 as compared to the average year-on-year growth during 2017-2019. The rise in CAGR is attributable to this market growth and demand, returning to pre-pandemic levels once the pandemic is over.


The market is gaining significant traction after introduction of insulin pump by leading market players such as Medtronic, Insulet Corporation etc. The market is projected to expand at considerable growth rate owing to the key factors such as growing prevalence of chronic diseases, advancements in drug delivery technologies, and increasing adoption of these techniques in the emerging regions. This pump is a medical device used to deliver fluids such as nutrients and medicines to the patient in a controlled amount. These are designed based on the specialized functions such as enteral feeding pumps to deliver nutrients, insulin pumps to deliver insulin, and patient controlled analgesia (PCA) pumps for delivery of pain medications. Various routes utilized for fluid delivery by these pumps include intravenous, subcutaneous, and arterial. The practice of these pumps has been encouraged over the manually driven flow control method to provide accurate and exact delivery of the fluid and achieve therapeutic efficacy.


Demand for Pumps in Disease Management of COVID-19 Infection to Improve Business Prospects


Due to the impact of the COVID-19 pandemic and the uncertainties regarding the duration, the industry has witnessed a strong upward spike in its growth rate. This is majorly due to the increase in the COVID-19 testing during the year 2020. However, due to the unavailability of workers and supply chain disruptions there was a decline in the production due to the COVID-19 pandemic.


For instance, Baxter international has experienced significant and unpredictable reductions and increases in the demand of certain healthcare products during the COVID-19 pandemic. However, new product launches have uplifted the revenue growth in the year 2020. For instance, In January 2020, Medtronic, Ireland has launched Efficio networked with the SynchroMed II intrathecal drug delivery system.


LATEST TRENDS


Request a Free sample to learn more about this report.


Growing Research and Development Activities to Launch Home Infusion Systems


The growing prevalence of chronic diseases coupled with increasing cost of hospital-based infusion therapies has resulted into growing research and development activities to develop home-based infusion products. For instance, growing patient population in diabetes, cancer, and neurological disorders has resulted in growing demand for long term care preferably at home care settings. Moreover, growing geriatric population in need of long-term care therapies is driving the new product developments targeting home-based infusion therapies. The leading players in the market are focusing on site of care management for specialty medicines. In August 2020, Ivenix, Inc. has developed a smart infusion pump named as Epic which helps to eliminate infusion-based injuries of patients.


DRIVING FACTORS


Growing Prevalence of Chronic Diseases to Boost Market Growth


Infusion pumps provide important advantages over the manual delivery of fluids like the ability to administer the fluids in a very small dosage and at accurate programmed rates. In many cases like cancer and diabetic conditions, these pumps are used to deliver the medication to maintain drug level in the bloodstream at a steady state. According to the World Health Organization (WHO), in 2018, cancer was estimated to be the second most prominent cause of death globally and is responsible for about 9.6 million deaths. Cancer patients require chemotherapy which is to be delivered to the patients in a continuous manner which can be achieved by using the pump. Moreover, according to the Centers for Disease Control and Prevention (CDC), in 2020, the prevalence of diabetes was estimated to be around 463 million cases worldwide and in the U.S., 34.2 million adults have diabetes which is 10.5% of the total population. The insulin pumps are increasingly being preferred in the management of type 1 diabetes. These patients necessitate user friendly self-controlled pumps to achieve continuous medication delivery. Together, these factors are surging the infusion pump market growth across all regions.


Growing Demand for Ambulatory Pumps to Propel the Market Growth


Ambulatory pump is a significant means of drug delivery in a wide range of medical situations. They play a vital role in supplying analgesics, chemotherapy, TPN infusion, and other infusions to patients in both hospitals and home care settings. In developed countries, the shift to site of care management of chronic diseases for the reduction of cost burdens associated with hospitals-based management is likely to increase demand for portable pumps in near future.


RESTRAINING FACTORS


Stringent Regulations for the Production of Pumps to Restrain Market Growth


Increasingly stringent regulations regarding the production and incorporation of pumps slow down the approval process for new products. This factor is anticipated to restrain the market growth. Moreover, increasing product recalls due to product errors are restricting the market growth. In August 2019, for example, Fresenius Kabi recalled Vigilant Agilia drug library and Volumat MC Agilia infusion pump due errors to an infusion alarm, low priority keep vein open (KVO), and multiple errors associated with software.


SEGMENTATION


By Type Analysis


To know how our report can help streamline your business, Speak to Analyst


Insulin Pump Segment to Hold Leading Share of the Market Due to Growing Number of Diabetic Patients


Based on type, the market is segmented into volumetric pumps, syringe pumps, enteral feeding pumps, insulin pump, elastomeric pumps, implantable pump, and patient control analgesia (PCA) pumps. Globally the insulin pump segment dominated the global market. The segment is projected to continue its dominance by expanding at significantly high growth rate during the forecast period. This is attributable to growing number of type 1 diabetic patient population globally and introduction of promising technologies in insulin pump area. Growing applications of PCA pumps in pain management are likely to boost the global product demand in coming years.


By Application Analysis


Diabetes Application Segment to Hold Lions Share Due to Increasing Prevalence of Diabetes around Globe


In terms of application, market segments include diabetes, oncology, pain management, and others. Among them, the diabetes segment held largest infusion pump market share in the year 2020. The segment is estimated to grow at highest CAGR during the forecast period. The oncology segment is expected to witness significant traction owing to the growing prevalence of various cancers and increasing new product launches in this area. Other application areas of this pump includes gastroenterology, hematology, pediatrics, and anesthesia, blood transfusion, and others.


By End User Analysis


Hospitals segment to Dominate Global Market Due to increasing Hospital Admissions Globally


Based on the end users, the market is segmented into hospitals, ambulatory care settings, specialty clinics and home care settings. Among them, the hospitals segment accounted for the largest share of the market in the year 2020 due to hospitals’ high procuring power of costliest infusion devices, large patient pool visiting these facilities, and the readiness of trained staff to operate the pump. However, home care settings segment is expected to grow at the highest CAGR during the forecast period due to the growing adoption of ambulatory pumps and increasing preference for site of care management to reduce cost burden. Moreover, increasing government initiatives for the reduction of overall healthcare costs associated with prolonged hospitalization is likely to support the rising demand for infusion systems in the homecare setting.


REGIONAL ANALYSIS


North America Infusion Pump Market Size, 2020 (USD Billion)

To get more information on the regional analysis of this market, Request a Free sample


The global infusion pump market size in North America stood at USD 3.52 billion in 2020. The market in the region in characterized by higher diagnosis and treatment rates for diabetes coupled with high adoption of ambulatory pumps, and favorable reimbursement policies in the region. Technological advancement related to the medical devices in the North America region is boosting the growth of the region. Europe held second largest share of the market. An increase in the prevalence of chronic diseases in this region and significant expenditure in the healthcare sector by the European Commission are anticipated to drive the demand for these pumps in Europe during 2021-2028.


To know how our report can help streamline your business, Speak to Analyst


The market in the emerging regions such as Asia Pacific, Latin America, and the Middle East & Africa region is projected to register comparatively higher CAGR during the forecast period. Rise in the prevalence of chronic diseases such as diabetes and cancer, growing healthcare infrastructure, growing GDP, disposable income is redundant, and increasing awareness about the availability of advanced therapies in Asia Pacific region are some of the factors projected to drive the market growth in this region in upcoming years. The market in Latin America and the Middle East & Africa is currently in nascent stage. However, increasing focus of leading players to expand their presence will augment the market in these regions.


KEY INDUSTRY PLAYERS


Strong Geographic Presence of Key Players Owing to Strong Expansion strategies and Product Diversification


The market is characterized by presence of large number of major players offering various types of pumps in diverse application categories. The market is highly fragmented however, companies like Becton Dickinson, Baxter, and Medtronic, are successful to maintain dominating positions in their respective segment product categories. Expansion of product portfolio through organic as well as inorganic growth and strengthening of distribution channels across all the regions of the globe including emerging countries such as India, China, and Brazil are major winning imperatives to be noted. The regional players are making this market competitive by increasing pricing pressure. Other prominent players studied in the report include icumedical, B. Braun Melsungen AG.


LIST OF KEY COMPANIES PROFILED:



  • Medtronic (Ireland)

  • Becton Dickinson and Company (U.S.)

  • Baxter (U.S.)

  • Insulet Corporation (U.S.)

  • ICU Medical, Inc. (U.S.)

  • B. Braun Melsungen AG (Germany)

  • Smiths Medical (Smiths Group plc.) (U.S.)

  • Fresenius Kabi AG (Germany)

  • Terumo Corporation (Japan)

  • F. Hoffmann-La Roche Ltd (Switzerland)

  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)


KEY INDUSTRY DEVELOPMENTS:



  • April 2021- Medtronic has launched world’s first and only infusion set that can be used for up to seven days in select European countries. This set is responsible for delivering insulin from the pump into the human body. This new set is compatible with all MiniMed 600 and 700 series insulin pumps.

  • August 2020- Mindray has launched new generation infusion system named as BeneFusion n Series. It offers deep insights into the safety of patient, interoperability and data management, operational simplicity which helps in setting new standards in infusion therapy.


REPORT COVERAGE


An Infographic Representation of Infusion Pump Market

To get information on various segments, share your queries with us



The market report provides a detailed analysis of the market and focuses on key aspects such as leading companies, product types, and leading applications of the product. Besides this, the report offers insights into the market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the market over the recent years.


Report Scope & Segmentation



















































  ATTRIBUTE



  DETAILS



Study Period



2017-2028



Base Year



2020



Estimated Year



2021



Forecast Period



2021-2028



Historical Period



2017-2019



Unit



Value (USD billion)



Segmentation



Type; Application; End User; and Region



Segmentation



By Type



  • Volumetric Pumps

  • Syringe Pumps

  • Elastomeric Pumps

  • Insulin Pumps

  • Enteral Pumps

  • Implantable Pumps

  • Patient Control Analgesia (PCA) Pumps



By Application



  • Diabetes

  • Oncology

  • Pain Management

  • Others 



By End User



  • Hospitals

  • Ambulatory Care Settings

  • Specialty Clinics

  • Home Care Settings



By Geography



  • North America (By Type, By Application, By End User, and by Country)

    • U.S. (By Type)

    • Canada (By Type)



  • Europe (By Type, By Application, By End User, and by Country)

    • U.K. (By Type)

    • Germany (By Type)

    • France (By Type)

    • Italy (By Type)

    • Spain (By Type)

    • Rest of Europe (By Type)



  • Asia Pacific (By Type, By Application, By End User, and by Country)

    • China (By Type)

    • Japan (By Type)

    • India (By Type)

    • Australia (By Type)

    • Southeast Asia (By Type)

    • Rest of Asia Pacific (By Type)



  • Latin America (By Type, By Application, By End User, and by Country)

    • Brazil (By Type)

    • Mexico (By Type)

    • Rest of Latin America (By Type)



  • Middle East & Africa (By Type, By Application, By End User, and by Country)

    • GCC (By Type)

    • South Africa (By Type)



  • Rest of Middle East & Africa (By Type)



Frequently Asked Questions

Fortune Business Insights says that the global market size was USD 9.02 billion in 2020 and is projected to reach USD 15.81 billion by 2028.

In 2020, the market value stood at USD 9.02 billion.

The market is projected to grow at a CAGR of 7.3%, during the forecast period (2021-2028).

Insulin Pump segment is the leading segment in this market.

Increasing prevalence of chronic diseases like cancer and diabetes is the key factor driving the market

Medtronic, BD, and Baxter international are the leading player in the global market.

North America held the highest market share in the market in 2020.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
  • Feb, 2022
  • 2020
  • 2017-2019
  • 135

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X